Nutlin-3 [548472-68-0]
N8277
Estimated Purity≥95%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameNutlin-3 [548472-68-0]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥95%
- FormatDMSO 100 mg/mL (171.96 mM); Ethanol 30 mg/mL (51.59 mM); Water Insoluble
- Scientific DescriptionImidzoline derivative; MDM2 inhibitor.; Nutlin3
- Storage Instruction-20°C
- UNSPSC12352200
References
- Shi X, Liu J, Ren L, et al. Nutlin-3 downregulates p53 phosphorylation on serine(392) and induces apoptosis in hepatocellular carcinoma cells. BMB Rep. 2014 Apr;47(4):221-6. PMID: 24286312. Choe YJ, Lee SY, Ko KW, et al. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53. Int J Oncol. 2014 Mar;44(3):761-8. PMID: 24366007. Wu Y, Fu Y, Zheng L, et al. Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-bèta1-Smad-Snail/Slug axis. Cancer Lett. 2014 Jan 1;342(1):82-91. PMID: 24001610. Secchiero P, Toffoli B, Melloni E, et al. The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. Acta Diabetol. 2013 Dec;50(6):899-906. PMID: 23615706. Tisato V, Norcio A, Voltan R, et al. MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies. Curr Med Chem. 2013;20(17):2226-36. PMID: 23458617.